6606 POSTER Three drug regimen in SCLC-ED patients: a phase II study.

MLA

Syrigos, K., et al. “6606 POSTER Three Drug Regimen in SCLC-ED Patients: A Phase II Study.” EJC Supplements, vol. 5, no. 4, Aug. 2007, p. 390. EBSCOhost, https://doi.org/10.1016/S1359-6349(07)71434-9.

APA

Syrigos, K., Pantazopoulos, K., Charpidou, A., Gkiozos, I., Tzannou, I., Alamara, C., Dilana, K., Kotteas, E., & Katirtzoglou, N. (2007). 6606 POSTER Three drug regimen in SCLC-ED patients: a phase II study. EJC Supplements, 5(4), 390. https://doi.org/10.1016/S1359-6349(07)71434-9

Chicago

Syrigos, K., K. Pantazopoulos, A. Charpidou, I. Gkiozos, I. Tzannou, C. Alamara, K. Dilana, E. Kotteas, and N. Katirtzoglou. 2007. “6606 POSTER Three Drug Regimen in SCLC-ED Patients: A Phase II Study.” EJC Supplements 5 (4): 390. doi:10.1016/S1359-6349(07)71434-9.